Sign in

CIK 0001001233

  • Non-accelerated filer
  • Smaller reporting company

SANGAMO THERAPEUTICS, INC

Sign in to watch
Ticker
SGMOQ
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680359556
Phone
+1 510-970-6000
Business address
501 CANAL BLVD., RICHMOND, CA, 94084
Former names
SANGAMO BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-12 Hillan Kenneth J. Director Grant or award +25,000 99,600
2025-06-12 Hillan Kenneth J. Director Grant or award · Stock Option (Right to Buy) +50,000 50,000
2025-06-12 Carey Robert Director Grant or award +25,000 99,600
2025-06-12 Carey Robert Director Grant or award · Stock Option (Right to Buy) +50,000 50,000
2025-06-12 Beers Courtney Director Grant or award +25,000 82,650
2025-06-12 Beers Courtney Director Grant or award · Stock Option (Right to Buy) +50,000 50,000
2025-05-24 Davis Gregory D Head of Research & Technology Shares withheld for taxes −723 $0.47 $342 208,653
2025-05-24 Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY Shares withheld for taxes −1,433 $0.47 $678 781,543
2025-05-24 Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER Shares withheld for taxes −1,792 $0.47 $848 799,747
2025-05-24 Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER Shares withheld for taxes −1,792 $0.47 $848 778,145
2025-05-24 Macrae Sandy PRESIDENT, CEO AND DIRECTOR Shares withheld for taxes −7,488 $0.47 $4K 2,318,410
2025-04-22 Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY Shares withheld for taxes −31,866 $0.78 $25K 782,976
2025-04-22 Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER Shares withheld for taxes −31,866 $0.78 $25K 779,937
2025-04-22 Macrae Sandy PRESIDENT, CEO AND DIRECTOR Shares withheld for taxes −126,950 $0.78 $99K 2,325,898
2025-04-22 Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER Shares withheld for taxes −31,866 $0.78 $25K 801,539
2025-04-22 Davis Gregory D Head of Research & Technology Shares withheld for taxes −6,708 $0.78 $5K 209,376
2025-02-25 Davis Gregory D Head of Research & Technology Shares withheld for taxes −507 $0.96 $485 166,358
2025-02-25 Davis Gregory D Head of Research & Technology Grant or award +49,726 216,084
2025-02-25 Davis Gregory D Head of Research & Technology Grant or award · Stock Option (Right to Buy) +99,454 99,454
2025-02-25 Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER Shares withheld for taxes −1,513 $0.96 $1K 713,405

Page 4 of 9 · 165 trades